Brad Niles, PhD
Chief Executive Officer
20 years experience in cancer research and product development
Glenn Kazo
Chief Business Officer
Founder of Enzon, inventor of Pegylation technology. Had a leading role in 3 IPOs and raised over $500M
Lonnie Bookbinder, PhD, MBA
Board Chairman
Leadership in pharma industry, drug licensing to pharma, serial entrepreneur, 47 years in industry
Narendra Vaish, PhD
siRNA Drug Development
Expert in RNA Inhibition and siRNA drug design with >100 biomed patent applications
Sundeep Dugar, PhD
Pre-clinical Drug Development
>30 years in drug development (Scios, J&J, BMS, Schering- Plough, Sphaera Pharma, Epirium Bio, Aayam Therapeutics)
Shi Huang, PhD
Scientific Advisor
Discoverer or PRDM family, Professor at Central South University, China
Dean Felsher, MD, PhD
Scientific Advisor
Professor of Medicine (Oncology) and oncogene researcher at Stanford School of Medicine
H. Michael Shepard, PhD
Scientific Advisor
Lasker Award winner and inventor of Herceptin for Genentech
Rupesh Chaturvedi, PhD
Scientific Advisor
Immunology and Cancer researcher, Professor at Jawaharlal Nehru University, India
Lokesh Sikaria
Board Member
Founder and Managing Director at Moneta Ventures
Kevin Nagle
Board Member
Investor, co-Founder of EnvisionRx Options, former Upjohn executive, co-Owner of Sacramento Kings (NBA) and Sac Republic FC (MLS)
Dr. Manish Bhandari
Board Member
Managing Partner, Angel Physicians Fund
Contact Us